Synapse - Mark Frattini

Results (45)

Small molecule inhibition of Cdc7, a key cell cycle regulator and novel therapeutic target, successfully inhibits leukemia cell growth in vitro and in vivo

Meeting Abstract

Frattini, M. G.; Shum, D.; O'dwyer, K. M.; Brentjens, R. J.; Yeh, R.; Maslak, P.; Heaney, M. L.; Jurcic, J.; Djaballah, H.; Kelly, T. J.
Blood (2008)

Fulltext@MSK | Save

Multiple mechanisms contribute to Schizosaccharomyces pombe origin recognition complex-DNA interactions

Journal Article

Houchens, C. R.; Lu, W.; Chuang, R. Y.; Frattini, M. G.; Fuller, A.; Simancek, P.; Kelly, T. J.
Journal of Biological Chemistry (2008)

Fulltext@MSK | Save

High-throughput profiling of leukemia cells for the identification of novel chemical scaffold signatures predicting disease-specific sensitivities

Meeting Abstract

Shum, D.; Santos, R.; Djaballah, H.; Frattini, M. G.
Cancer Research (2007)

Fulltext@MSK | Save

Phase I trial of the targeted alpha-particle nano-generator actinium-225 (Ac-225)-HuM195 (Anti-CD33) in acute myeloid leukemia (AML)

Meeting Abstract

Rosenblat, T. L.; McDevitt, M. R.; Pandit-Taskar, N.; Carrasquillo, J. A.; Chanel, S.; Frattini, M. G.; Larson, S. M.; Scheinberg, D. A.
Blood (2007)

Fulltext@MSK | Save

High throughput profiling of leukemia and lymphoma cell lines using small molecules: In search of conserved and novel chemical scaffold signatures effective for specific diseases

Meeting Abstract

Frattini, M. G.; Shum, D.; Santos, R.; Ahmed, A.; Djaballah, H.; Kelly, T. J.
Cancer Research (2006)

Fulltext@MSK | Save